Dr. Preston D. Steen
Claim this profileSanford Roger Maris Cancer Center
Expert in Cancer
Expert in Lung Cancer
113 reported clinical trials
192 drugs studied
About Preston D. Steen
Education:
- Obtained MD from the University of North Dakota School of Medicine & Health Sciences (2015).
- Completed Residency in Internal Medicine at the University of Minnesota Medical Center (2018).
- Finished Fellowship in Hematology/Oncology at the Mayo Clinic, Rochester, Minnesota (2021).
Experience:
- Currently practices as a hematologist and oncologist at Sanford Roger Maris Cancer Center.
- Specializes in internal medicine, hematology, and oncology.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Preston D. Steen is currently running
Stereotactic Radiation + Immunotherapy
for Kidney Cancer
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.
Recruiting1 award Phase 221 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Preston D. Steen
Clinical Trial Related4 years of experience running clinical trials · Led 113 trials as a Principal Investigator · 57 Active Clinical TrialsTreatments Preston D. Steen has experience with
- Nivolumab
- Cisplatin
- Atezolizumab
- Pembrolizumab
- Carboplatin
- Ipilimumab
Breakdown of trials Preston D. Steen has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Preston D. Steen specialize in?
Preston D. Steen focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Preston D. Steen currently recruiting for clinical trials?
Yes, Preston D. Steen is currently recruiting for 53 clinical trials in Fargo North Dakota. If you're interested in participating, you should apply.
Are there any treatments that Preston D. Steen has studied deeply?
Yes, Preston D. Steen has studied treatments such as Nivolumab, Cisplatin, Atezolizumab.
What is the best way to schedule an appointment with Preston D. Steen?
Apply for one of the trials that Preston D. Steen is conducting.
What is the office address of Preston D. Steen?
The office of Preston D. Steen is located at: Sanford Roger Maris Cancer Center, Fargo, North Dakota 58122 United States. This is the address for their practice at the Sanford Roger Maris Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.